BAMCO Inc’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-74,373
Closed -$24.2M 354
2024
Q1
$24.2M Sell
74,373
-391
-0.5% -$96K 0.06% 199
2023
Q4
$14.2M Buy
74,764
+12,034
+19% +$2.27M 0.04% 216
2023
Q3
$12.5M Buy
62,730
+18,650
+42% +$4.41M 0.04% 222
2023
Q2
$12.6M Sell
44,080
-1,523
-3% -$423K 0.03% 228
2023
Q1
$9.89M Sell
45,603
-14,988
-25% -$2.92M 0.03% 231
2022
Q4
$12.5M Buy
60,591
+2,186
+4% +$553K 0.04% 211
2022
Q3
$16.2M Sell
58,405
-36,122
-38% -$9.19M 0.05% 211
2022
Q2
$18.1M Sell
94,527
-45,113
-32% -$7.96M 0.06% 216
2022
Q1
$29M Sell
139,640
-5,665
-4% -$934K 0.07% 191
2021
Q4
$25.9M Sell
145,305
-10,055
-6% -$1.98M 0.06% 237
2021
Q3
$32M Buy
155,360
+2,601
+2% +$511K 0.07% 218
2021
Q2
$29M Sell
152,759
-6,313
-4% -$1.03M 0.07% 223
2021
Q1
$20.7M Buy
159,072
+2,215
+1% +$266K 0.05% 231
2020
Q4
$16.3M Buy
156,857
+3,200
+2% +$277K 0.04% 238
2020
Q3
$11.6M Buy
153,657
+147,331
+2,329% +$8.35M 0.04% 237
2020
Q2
$300K Buy
+6,326
New +$261K ﹤0.01% 294

Other funds holding SWAV

BAMCO Inc's SWAV Position: Q2 2024 in Review

BAMCO Inc sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 74,373 shares — an estimated $24.2M sold.

BAMCO Inc first reported a position in SWAV in Q2 2020 and held it in 16 quarters. The position peaked at $32M in Q3 2021. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • BAMCO Inc reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • BAMCO Inc sold 74,373 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $24.2M.
  • BAMCO Inc first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
  • BAMCO Inc's Shockwave Medical, Inc. Common Stock position peaked at $32M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on BAMCO Inc's 13F filing for Q2 2024, filed 14 Aug 2024.